{"id":164,"date":"2025-09-09T17:26:58","date_gmt":"2025-09-09T15:26:58","guid":{"rendered":"https:\/\/www.barnaclinic.com\/blog\/memoria\/?p=164"},"modified":"2025-09-09T17:28:30","modified_gmt":"2025-09-09T15:28:30","slug":"frontotemporal-dementia","status":"publish","type":"post","link":"https:\/\/www.barnaclinic.com\/blog\/memoria\/en\/frontotemporal-dementia\/","title":{"rendered":"Frontotemporal dementia: symptoms, diagnosis, and available treatments"},"content":{"rendered":"

Frontotemporal dementia (FTD)<\/strong> is a type of neurodegenerative dementia<\/strong> less common than Alzheimer\u2019s disease<\/strong><\/a>, but with a great impact on the patient\u2019s life and their environment. Unlike other dementias<\/strong><\/a>, it usually begins at an earlier age, between 45 and 65 years, and its main symptom is not related to memory<\/a>, but to behavior.<\/p>\n

<\/p>\n

What is frontotemporal dementia?<\/h2>\n

FTD mainly affects the frontal and temporal lobes of the brain, responsible for behavior, language, and decision-making. Therefore, the most common initial symptom is a behavioral disorder<\/strong>: personality changes, difficulty controlling impulses, apathy, or loss of empathy.<\/p>\n

Differences with Alzheimer\u2019s disease<\/h2>\n

In its early stages, frontotemporal dementia<\/strong> can be mistaken for Alzheimer\u2019s disease<\/strong><\/a>. However, while in Alzheimer\u2019s the main alteration is memory<\/strong>, in FTD the most significant change is behavior<\/strong>. This distinction is essential to guide the diagnosis of frontotemporal dementia<\/strong> and define the therapeutic approach.<\/p>\n

\n

\"Albert<\/em><\/h4>\n

\u201cFrontotemporal dementia is mainly characterized by a behavioral disorder, unlike Alzheimer\u2019s, which affects memory more severely\u201d<\/h4>\n

Dr. Albert Llad\u00f3<\/strong><\/a>, neurologist specialized in dementias<\/p>\n

How is frontotemporal dementia diagnosed?<\/h2>\n<\/blockquote>\n

The diagnosis of FTD<\/strong> is clinical<\/strong> and requires a detailed neuropsychological<\/a> and neurological evaluation<\/strong>. To complete the study, neuroimaging<\/strong> tests are used, such as MRI, CT scan, or nuclear medicine tests such as glucose PET, which help confirm brain involvement.<\/p>\n

Treatment of frontotemporal dementia<\/h2>\n

Currently, there is no pharmacological treatment for frontotemporal dementia<\/strong>. However, there are non-pharmacological treatments<\/strong> that can improve patients\u2019 quality of life and slow down the progression of some symptoms.
Among them, the most relevant are:<\/p>\n

    \n
  • \n

    Occupational therapy and cognitive stimulation<\/strong>, which help maintain autonomy and preserved abilities.<\/p>\n<\/li>\n

  • \n

    Speech therapy<\/strong>, especially in cases of primary progressive aphasia<\/em>, a variant of FTD in which language is the most affected function.<\/p>\n<\/li>\n

  • \n

    Psychological support and psychoeducation<\/strong> for families and caregivers, essential for managing behavioral changes.<\/p>\n<\/li>\n<\/ul>\n

    \n